HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
trastuzumab biosimilar HLX02
Networked:
2
relevant articles (
0
outcomes,
1
trials/studies)
Bio-Agent Context: Research Results
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Blood Proteins: 12459
Serum Globulins: 553
Immunoglobulins: 30480
Antibodies: 133716
Monoclonal Antibodies: 56412
Humanized Monoclonal Antibodies: 217
Trastuzumab: 9058
trastuzumab biosimilar HLX02: 2
Immunoproteins: 43
Immunoglobulins: 30480
Antibodies: 133716
Monoclonal Antibodies: 56412
Humanized Monoclonal Antibodies: 217
Trastuzumab: 9058
trastuzumab biosimilar HLX02: 2
Globulins: 3062
Serum Globulins: 553
Immunoglobulins: 30480
Antibodies: 133716
Monoclonal Antibodies: 56412
Humanized Monoclonal Antibodies: 217
Trastuzumab: 9058
trastuzumab biosimilar HLX02: 2
Complex Mixtures: 1906
Biological Products
Biosimilar Pharmaceuticals: 1758
trastuzumab biosimilar HLX02: 2
Related Diseases
1.
Breast Neoplasms (Breast Cancer)
01/01/2023 - "
A multicenter real-world study comparing the clinical equivalence of trastuzumab biosimilar HLX02 and reference trastuzumab in the treatment of HER-2-positive breast cancer.
"
10/01/2022 - "
Trastuzumab biosimilar HLX02 versus reference trastuzumab in patients with recurrent or metastatic HER2-positive breast cancer: a model-based economic evaluation for China.
"
Related Drugs and Biologics
1.
Trastuzumab (Herceptin)